CTNM
Contineum Therapeutics, Inc.
12.60$
+0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 0.00 | 0.00 | 1.99 | 0.00 | 0.00 | |
| – | 0.01 | 0.01 | 0.01 | 0.01 | |
| – | -0.01 | 1.99 | -0.01 | -0.01 | |
| 0.89 | 0.67 | 1.10 | 1.48 | 1.86 | |
| 0.25 | 0.23 | 0.25 | 0.48 | 0.60 | |
| 1.14 | 0.90 | 2.63 | 1.96 | 2.46 | |
| -1.14 | -0.90 | -0.64 | -1.97 | -2.46 | |
| 0.01 | 0.02 | 0.01 | 0.00 | – | |
| -1.15 | -0.97 | 0.92 | -1.63 | -2.17 | |
| 0.01 | – | 0.02 | – | – | |
| -1.15 | -0.97 | 0.90 | -1.63 | -2.17 | |
| -1.13 | -0.94 | 0.94 | -1.62 | -2.45 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.